Oragenics, Inc.
OGEN
$0.59
$0.035.45%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 670.50K | 930.90K | 449.70K | 341.50K | 1.67M |
| Gross Profit | -670.50K | -930.90K | -449.70K | -341.50K | -1.67M |
| SG&A Expenses | 1.83M | 2.19M | 1.26M | 1.68M | 1.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.50M | 3.12M | 1.71M | 2.03M | 3.36M |
| Operating Income | -2.50M | -3.12M | -1.71M | -2.03M | -3.36M |
| Income Before Tax | -2.42M | -3.07M | -2.27M | -2.22M | -3.35M |
| Income Tax Expenses | -136.90K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.29M | -3.07M | -2.27M | -2.22M | -3.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.29M | -3.07M | -2.27M | -2.22M | -3.35M |
| EBIT | -2.50M | -3.12M | -1.71M | -2.03M | -3.36M |
| EBITDA | -- | -- | -- | -- | -3.35M |
| EPS Basic | -0.54 | -1.96 | -3.10 | -3.65 | -5.00 |
| Normalized Basic EPS | -0.36 | -1.23 | -1.94 | -2.28 | -3.13 |
| EPS Diluted | -0.54 | -1.96 | -3.10 | -3.65 | -5.00 |
| Normalized Diluted EPS | -0.36 | -1.23 | -1.94 | -2.28 | -3.13 |
| Average Basic Shares Outstanding | 4.23M | 1.56M | 731.80K | 607.10K | 669.30K |
| Average Diluted Shares Outstanding | 4.23M | 1.56M | 731.80K | 607.10K | 669.30K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |